- Outlining key differences in company budgets and pipelines
- How to align financial incentives between CROs and pharma so that both sides win
- Uniting in common challenges amongst all sponsors
- Lessons learned from partnerships that improved performance
- Balancing trust and transparency across the ecosystem
- Patient safety, innovation and adaptability as shared goals
Seats available
- Challenges of data silos and interoperability across research and clinical
- Strategies for creating a cohesive data ecosystem that supports translational research
- Case examples of successful data integration improving patient outcomes or accelerating drug development
- Predictive and prognostic biomarker discovery through advanced analytics.
- Regulatory and validation considerations for clinical implementation
- Future-facing models: What will define a ‘remarkable’ trial in the next decade?
- Leveraging adaptive and decentralized trial designs to improve flexibility and speed
- Empowering sites and CROs as partners to improve patient outcomes
- Strengthening communication to avoid misaligned expectations in the face of global disruptions
- Reducing costs and environmental impact while maintaining scientific integrity
